India · Delayed Price · Currency is INR Hemo Organic Statistics
Total Valuation
Hemo Organic has a market cap or net worth of INR 69.70 million. The enterprise value is 97.00 million.
| Market Cap | 69.70M |
| Enterprise Value | 97.00M |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hemo Organic has 3.47 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 3.47M |
| Shares Outstanding | 3.47M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 40.71% |
| Owned by Institutions (%) | 8.08% |
| Float | 1.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.49 |
| PB Ratio | 52.44 |
| P/TBV Ratio | 52.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 20.62.
| Current Ratio | 2.81 |
| Quick Ratio | 1.95 |
| Debt / Equity | 20.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.88 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.60% |
| Return on Invested Capital (ROIC) | -14.83% |
| Return on Capital Employed (ROCE) | -17.34% |
| Weighted Average Cost of Capital (WACC) | 4.85% |
| Revenue Per Employee | 1.86M |
| Profits Per Employee | -1.56M |
| Employee Count | 5 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 0.97 |
Taxes
In the past 12 months, Hemo Organic has paid 2.80 million in taxes.
| Income Tax | 2.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +102.29% in the last 52 weeks. The beta is 0.46, so Hemo Organic's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +102.29% |
| 50-Day Moving Average | 14.28 |
| 200-Day Moving Average | 13.14 |
| Relative Strength Index (RSI) | 63.11 |
| Average Volume (20 Days) | 16,356 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemo Organic had revenue of INR 9.31 million and -7.78 million in losses. Loss per share was -2.24.
| Revenue | 9.31M |
| Gross Profit | 17,000 |
| Operating Income | -4.98M |
| Pretax Income | -4.98M |
| Net Income | -7.78M |
| EBITDA | -4.98M |
| EBIT | -4.98M |
| Loss Per Share | -2.24 |
Balance Sheet
The company has 109,000 in cash and 27.41 million in debt, with a net cash position of -27.30 million or -7.88 per share.
| Cash & Cash Equivalents | 109,000 |
| Total Debt | 27.41M |
| Net Cash | -27.30M |
| Net Cash Per Share | -7.88 |
| Equity (Book Value) | 1.33M |
| Book Value Per Share | 0.38 |
| Working Capital | 28.71M |
Cash Flow
In the last 12 months, operating cash flow was -14.58 million and capital expenditures -15,000, giving a free cash flow of -14.60 million.
| Operating Cash Flow | -14.58M |
| Capital Expenditures | -15,000 |
| Depreciation & Amortization | 6,000 |
| Net Borrowing | 12.61M |
| Free Cash Flow | -14.60M |
| FCF Per Share | -4.21 |
Margins
Gross margin is 0.18%, with operating and profit margins of -53.52% and -83.58%.
| Gross Margin | 0.18% |
| Operating Margin | -53.52% |
| Pretax Margin | -53.52% |
| Profit Margin | -83.58% |
| EBITDA Margin | -53.46% |
| EBIT Margin | -53.52% |
| FCF Margin | n/a |
Dividends & Yields
Hemo Organic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -11.16% |
| FCF Yield | -20.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hemo Organic has an Altman Z-Score of -0.2 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.2 |
| Piotroski F-Score | 1 |